Biopharmaceutical Analysis

More Sensitive Adventitious Agent Testing

Complex modalities put pressure on detection and testing processes.

Protein Characterization for Regulatory Submissions

A clear understanding of the biomolecule is essential.

Near Infrared Spectroscopy as a Versatile PAT Tool for Continuous Downstream Bioprocessing

March 02, 2021

The need for real-time monitoring and control has spurred the development of new analytical tools.

Toxicology: Ensuring Drugs are Safe for People

March 01, 2021

Accelerated drug development timelines must accommodate all crucial elements of nonclinical safety studies.

Roche and Cambridge Quantum Computing Use Algorithms for Early Alzheimer's Drug Research

March 01, 2021

The companies intend to design and implement algorithms for the early stages of research for drug discovery and development of drug candidates to treat Alzheimer’s disease.

SPT Labtech Strengthens Automation Services with BioMicroLab Acquisition

March 01, 2021

The acquisition strategically expands SPT Labtech’s offering in sample management for life sciences.

Nexelis Expands Bioanalytical Services with Bioanalytical Lab Acquisition

January 28, 2021

Nexelis’ recent acquisition of GSK’s Marburg, Germany-based vaccines clinical bioanalytical laboratory expands its bioanalytical capabilities.

Almac Invests in Expanding Global Biologics Testing Solutions

January 28, 2021

The £500,000 (US$686,294)-investment in mass spectrometry support will accelerate biologics development and approval.

Talent-Driven Market for Laboratory Technicians

January 06, 2021

Demand for specific advanced laboratory skills creates a positive employment market.

rBIO Hits Key Lab Milestone with Synthetic Production of Insulin

January 04, 2021

Using rDNA technology to synthesize production of proteins and peptide hormones, the biotech startup has achieved synthetic production of insulin, potentially lowering insulin cost by 30%.

Biopharma Gets Back to “New Normal” Business

January 02, 2021

After a hectic 2020, biopharma looks to deliver on COVID-19 vaccines and move other promising therapies forward.

Compensation Does Not Necessarily Align with Job Satisfaction

January 02, 2021

Essential bio/pharma employees show hard work and dedication can pay off, for patients.